Prevention of murine cardiac allograft rejection with gallium nitrate: Comparison with anti-CD4 monoclonal antibody

Transplantation

Volumn 61, Issue 5, 1996, Pages 783-791

  Orosz, Charles G ^a,b   Wakely, Elaine ^a   Bergese, Sergio D ^a   VanBuskirk, Anne M ^a   Ferguson, Ronald M ^a   Mullet, Daniel ^a   Apseloff, Glen ^a   Gerber, Nicholas ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM NITRATE; OKT 4;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE; HEART GRAFT; HEART TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; FEMALE; GALLIUM; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MYOCARDIUM; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029993559     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603150-00019     Document Type: Article

References (36)

1. Darby CR, Morris PJ, Wood KJ. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ cells. Transplantation 1992; 54: 483.
2. Madsen JC, Peugh WN, Wood KJ, Morris PJ. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 1987; 44(6): 849.
3. Chavin KD, Qin L, Lin J, Yagita H, Bromberg JS. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model. J Immunol 1993; 151(12): 7249.
4. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125.
5. Orosz CG, Ohye RG, Pelletier RP, et al. Treatment with anti-VCAM-1 mAb induces long term murine cardiac allograft acceptance. Transplantation 1993; 56(2): 453.
6. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701.
7. Ohzato H, Monaco AP. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Transplantation 1992; 54: 1090.
8. Goss JA, Nakafusa Y, Yu S, Flye MW. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts. Transplantation 1993; 56: 166.
9. Nakafusa Y, Goss JA, Mohanakumar T, Flye MW. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen. Transplantation 1993; 55(4): 877.
10. Knechtle SJ, Wang J, Jiao S, Geissler EK, Sumimoto R, Wolff J. Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation 1994; 57: 990.
11. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. 1. Time course and immunogenetic and immunopathological considerations. Am J Pathol 1994; 144(2): 260.
12. Paul LC, Fellstrom B. Chronic vascular rejection of the heart and the kidney - have rational treatment options emerged? Transplantation 1992; 53: 1169.
13. Adams DH, Wyner LR, Karnovsky MJ. Experimental graft arteriosclerosis. II. Immunocytochemical analysis of lesion development. Transplantation 1993; 56: 794.
14. Paul LC, Davidoff A, Benediktsson H. Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine and angiotensin-converting enzyme inhibitor. Transplantation 1994; 57: 1767.
15. Cramer DV, Wu G-D, Chapman FA, Cajulio E, Wang H-K, Makowka L. Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis. J Heart Lung Transplant 1992; 11: 458.
16. Bishop DK, Chan S, Li W, Ensley RD, Xu S, Eichwald EJ. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 1993; 56 (4): 892.
17. Bishop DK, Li W, Chan SY, Ensley RD, Shelby J, Eichwald EJ. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Transplantation 1994; 58: 576.
18. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma. Transplantation 1994; 57: 1367.
19. Shizuru JA, Alters SE, Fathman CG. Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult. Immunol Rev 1992; 129: 105.
20. Pearson TC, Darby CR, Bushell AR, West LJ, Morris PJ, Wood KJ. The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation 1993; 55: 361.
21. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor foreceptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160.
22. Mottram PL, Han W-R, Purcell LJ, McKenzie IFC, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995; 59(4): 559.
23. Matkovic V, Apseloff G, Shepard DR, Gerber N. Use of gallium to treat Paget's disease of bone: a pilot study. Lancet 1990; 335: 72.
24. Huang EH, Gabler DM, Krecic ME, Gerber N, Ferguson RM, Orosz CG. Differential effects of gallium nitrate on T lymphocyte and endothelial cell activation. Transplantation 1994; 58(11): 1216.
25. Whitacre C, Apseloff G, Cox K, Matkovic V, Jewell S, Gerber N. Suppression of experimental autoimmune encephalomyelitis by gallium nitrate. J Neuroimmunol 1992; 39: 175.
26. Matkovic V, Balboa A, Clinchot D, et al. Gallium prevents adjuvant arthritis in rats and interferes with macrophage/T-cell function in the immune response. Curr Ther Res 1991; 50: 255.
27. Flynn JC, Serreze DV, Gerber N, Leiter EH. Chronic treatment of prediabetic non-obese diabetic (NOD) mice with gallium nitrate protected against the development of diabetes. Diabetes 1992; 41: 38A.
28. Corry R, Winn H, Ressell P. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343.
29. Barron DC, Haynes BW. Determination of gallium in phosphorus flue dust and other materials by graphite furnace atomic absorption spectrometry. Analyst 1986; 111: 19.
30. Pelletier RP, Ohye RG, Vanbuskirk A, et al. Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J Immunol 1992; 149: 2473.
31. Bishop DK, Shelby J, Eichwald EJ. Mobilization of T lymphocytes following cardiac transplantation Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Transplantation 1992; 53: 849.
32. Pelletier RP, Morgan CJ, Sedmak DD, et al. Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac grafts. Transplantation 1993; 55(2): 315.
33. Stepkowski SM, Raza-Ahmad A, Duncan WR. The role of class I and class II MHC antigens in the rejection of vascularized heart allografts in mice. Transplantation 1987; 44(6): 753.
34. Madsen JC, Superina RA, Wood KJ, Morris PJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1983; 332: 161.
35. Orosz CG, Bishop DK. Limiting dilution analysis of alloreactive T-cell status and distribution during allograft rejection. Hum Immunol 1990; 28: 72.
36. Morton AL, Bell EB, Bolton EM, et al. Cd4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody. Eur J Immunol 1993; 23: 2078.